Image
![South Central AETC Local Partner](/sites/default/files/styles/content_tiny/public/media/image/2022-02/S-Central-social-media-011122.png?itok=Q8cddN8B)
Training slides learning objective include:
- Applying the guidance provided by the AASLD/IDSA on hepatitis C virus (HCV) direct-acting antiviral (DAA) treatment interruptions
- Identifying when patients should have DAA therapy continued vs. when DAA therapy should be stopped
- Describing the data in patients with incomplete
Browse more